(Logo via Johnson & Johnson)

Dr. Paul Janssen Award for Biomedical Research Issues 2020 Call for Nominations to Celebrate Champions of Science

Originally published on jnj.com.

Nominations are now being accepted for the 2020 Dr. Paul Janssen Award for Biomedical Research. This prestigious award celebrates dedicated researchers and champions of science whose basic or clinical discoveries have made, or have the potential to make, significant contributions toward improving human health. Nominations will be accepted until February 29, 2020, at www.pauljanssenaward.com for consideration by an independent selection committee of world-renowned scientists. The winning scientist(s) will be announced in spring 2020 and receive a $200,000 cash prize.

The Dr. Paul Janssen Award for Biomedical Research honors Dr. Paul Janssen (1926-2003), one of the most productive pharmaceutical scientists of the 20th century. He was responsible for breakthrough treatments in disease areas, including pain management, psychiatry, infectious disease and gastroenterology. Janssen founded Janssen Pharmaceutica, N.V., now part of the Johnson & Johnson Family of Companies.

“Researchers pushing the boundaries of science are innovators and heroes. Their breakthroughs have the power to improve the lives of people around the world,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “It is a privilege to recognize those whose vision and commitment make scientific progression possible. We are proud to honor Dr. Paul’s legacy by recognizing outstanding researchers who are making a lasting impact on our world as he did.”

In 2019, the Dr. Paul Janssen Award recognized Drs. Franz-Ulrich Hartl M.D., Director, Max Planck Institute of Biochemistry and Arthur Horwich, M.D., Sterling Professor of Genetics and Professor of Pediatrics, Yale School of Medicine and Investigator, Howard Hughes Medical Institute, for their revolutionary insights into chaperone-mediated protein folding. They joined 16 other scientists who have received the Dr. Paul Janssen Award since its founding in 2004, including three who have gone on to win the Nobel Prize.

“Solving the world’s most pressing health problems requires continuous advancement of the science underlying biological processes,” said Richard P. Lifton, M.D., Ph.D., president of Rockefeller University. “This year, I’m honored to be chairing the selection committee, which reviews nominations from academia, industry, government and scientific institutions around the world. Each is a champion of science whose work exemplifies the leadership and passion that shaped Dr. Paul’s career.”

Previous Award winners include:

  • 2019 – Drs. Franz-Ulrich Hartl M.D., and Arthur Horwich, M.D.
  • 2018 – James Allison, Ph.D., Nobel Laureate
  • 2017 – Douglas Wallace, Ph.D.
  • 2016 – Yoshinori Ohsumi, Ph.D., Nobel Laureate
  • 2015 – Bert Vogelstein, M.D.
  • 2014 – Emmanuelle Charpentier, Ph.D. and Jennifer Doudna, Ph.D.
  • 2013 – David Julius, Ph.D.
  • 2012 – Victor Ambros, Ph.D., and Gary Ruvkun, Ph.D.
  • 2011 – Napoleone Ferrara, M.D.
  • 2010 – Anthony S. Fauci, M.D. and Erik De Clercq, M.D., Ph.D.,
  • 2009 – Axel Ullrich, Ph.D.
  • 2008 – Professor Marc Feldmann, FMedSci, FAA, FRS, Emeritus Professor and Sir Ravinder Maini, FRCP, FMedSci, FRS
  • 2006 – Craig Mello, Ph.D., Nobel Laureate

About The Dr. Paul Janssen Award for Biomedical Research
Established by Johnson & Johnson, The Dr. Paul Janssen Award salutes champions of science and the most passionate and creative scientists in basic or clinical research whose scientific achievements have made, or have strong potential to make, a measurable impact on human health.

The Award is named after the scientist who founded Janssen Pharmaceutica, N.V. in 1953. Known to his colleagues as “Dr. Paul,” Janssen helped save millions of lives through his contribution to the discovery and development of more than 80 medicines, four of which remain on the World Health Organization’s list of essential medicines.

In 1961, Janssen Pharmaceutica, N.V. joined the Johnson & Johnson Family of Companies. Janssen’s legacy continues to inspire Johnson & Johnson and its commitment to finding innovative cures for unmet medical needs. Visit www.pauljanssenaward.com for more information.

Latest News

ICE, whistleblower hysterectomies, COVID

ICE Whistleblower Alleges Unnamed Doctor Performing Hysterectomies, Denying COVID Tests to Detainees

At Immigration and Customs Enforcement (ICE) detainment centers, undocumented detainees are being subjected to “questionable” hysterectomies and are being denied COVID tests, according to a whistleblower. Dawn Wooten, a nurse who worked at the Irwin County Detention Center in Ocilla, GA recently filed a whistleblower complaint alleging medical neglect. A…

nielsen

Launching Nielsen Compass: A World-Leading and Powerful Campaign Outcomes Database

Originally published on nielsen.com. ADVERTISERS, AGENCIES AND PUBLISHERS TO LEVERAGE INSIGHTS FROM WORLD LEADING, OUTCOME MEASUREMENT DATASET TO MAKE DATA-DRIVEN DECISIONS, OPTIMIZE BUDGETS AND PREDICT SALES ROI Nielsen (NYSE: NLSN) today announced that it is launching Nielsen Compass, a powerful, world leading database that leverages the company’s global scale to…

Mastercard Outlines Sustainability Goals

Originally published on mastercardcontentexchange.com. Now is the time to work together to create a better world. If there’s a silver lining to this tumultuous time we’re living through, it’s that the pandemic has shown clearly just how interconnected we all are. The actions of an individual — whether by taking…

Cigna

Cigna Launches Evernorth to Accelerate Delivery of Innovative and Flexible Health Services and Flexible

Originally published on Cigna.com  Cigna Corporation (NYSE: CI) announces the launch of Evernorth, a new brand for its growing, high-performing health services portfolio. Evernorth will accelerate delivery of innovative and flexible solutions to meet the diverse needs of health plans, employers, and government organizations. Experience the interactive Multichannel News Release…

AT&T Works with Year Up to Close the Opportunity Divide

Originally published on ATT.com Young people are facing strong headwinds as they pursue career success in today’s economy. But there are bright spots. Now and in coming weeks, we’re highlighting individuals working hard to succeed despite their challenges. We’re raising awareness of what’s possible to inspire and encourage others. It’s…

ADP® DataCloud Wins 2020 Artificial Intelligence (AI) Breakthrough Award

Originally published on ADP.com Powerful workforce analytics solution honored for innovative application of predictive analytics and machine learning Recognized as a leading company in the global AI market today, ADP was selected as a winner in the 2020 AI Breakthrough Awards for its innovative workforce analytics solution, ADP® DataCloud. Named as winner for…